Eagle Pharmaceuticals Inc

NASDAQ:EGRX   3:59:51 PM EDT
47.60
-0.24 (-0.50%)
Products

Eagle Pharmaceuticals Submits Response To Complete Response Letter From FDA For Vasopressin

Published: 06/17/2021 11:07 GMT
Eagle Pharmaceuticals Inc (EGRX) - Eagle Pharmaceuticals Submits Response to Complete Response Letter From FDA for Vasopressin.
Eagle Pharmaceuticals - Anticipate Having Final Approval in Time to Launch Vasopressin This Year.